Triazole-Based Compound as a Candidate To Develop Novel Medicines To Treat Toxoplasmosis
Brak miniatury
Data
2014
Tytuł czasopisma
ISSN czasopisma
Tytuł tomu
Wydawca
Abstrakt
This article reports anti-Toxoplasma gondii activity of 3-(thiophen-2-yl)-1,2,4-triazole-5-thione. The compound displayed significant and reproducible antiparasitic effects at nontoxic concentrations for the host cells, with an experimentally determined
50% inhibitory concentration (IC50) at least 30 times better than that of the known chemotherapeutic agent sulfadiazine. Purine nucleoside phosphorylase was defined as the probable target for anti-Toxoplasma activity of the tested compound. These results
provide the foundation for future work to develop a new class of medicines to better treat toxoplasmosis.
Opis
Słowa kluczowe
Cytowanie
Antimicrobial Agents and Chemotherapy, Vol. 58, Issue 12, pages 7583-7585